We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Eden Research Plc | LSE:EDEN | London | Ordinary Share | GB0001646941 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 4.625 | 4.50 | 4.75 | 4.625 | 4.625 | 4.63 | 5,070 | 08:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Biological Pds,ex Diagnstics | 1.83M | -2.24M | -0.0042 | -11.00 | 24.64M |
Date | Subject | Author | Discuss |
---|---|---|---|
09/8/2020 11:44 | All the links on that page open perfectly well. It might be your computer PUGUGLY. pdf files | mirandaj | |
09/8/2020 11:22 | Follow up to 7994 * The recent appointee came from Plant Health Care - However is this a plus point when the progess of the PHC share price is factored in? * Just been following up the Eden website and neither 24/06/2020 AGM Questions and Answers nor 29/05/2020 2019 Annual Report will open when using standard click to open - Can anyone advise or is the site bust?? Edited -12:52pm Now working and opening OK Looks as though Mirandaj worked a miracle !!! * Not very encouraging that the combinded holing of the directors is 0.8% and current value of their combined holding is some £200,000 - Possibly less than some of the posters (or ex holders on this board) hold/held. However still looking at as appears to be in a very promising (ESG) sustainable area - OK maybe I should concentrate funds elsewhere as (e&oe) No UK agritech company has ever made real money for investors - either (imo) wrong products - scientific dead-end - not offering sufficient extra revenue to the users - or management lack sales skills or as the Yanks would say "The killer instinct" | pugugly | |
09/8/2020 11:00 | Hi SS - Neither of the 2 above patent links refer to Eden - They appear on the face to have have had funding support from US Gov and to have been granted to University of Mass - What am I missing re Eden? | pugugly | |
08/8/2020 15:30 | At some point you'd like to think sales will gain some traction.... Be nice if it ever gets UK approval...prob sat in some civil servants in tray collecting dust! | 33mick | |
08/8/2020 14:50 | You will not find facts just suppositions | chrischas | |
08/8/2020 13:46 | Good afternoon PaulpaoloI have searched TT' website but found no reference to your post, even after following your link. TT's last updated their website in April of this year.Where can I read more on this story?Stay safe. | northwick | |
07/8/2020 20:14 | Source? What are you referring too? | investingisatrickygame | |
05/8/2020 12:44 | Bottom line is Eden BOD has to get their finger out before it’s too late.Its being seen with Biochem Covid testing : you soon get market share taken when a new invention comes out. | chrischas | |
05/8/2020 12:34 | erinvale5 Aug '20 - 09:47 - 7985 of 7985 0 3 0 Sales are key. Eden seem incapable of achieving real sales - they've had 25 years and are still touting authorisations as progress. The market is not that easily fooled. -------------------- To be fair I don't think there's ANY interest in these currently. Any hot money has far warmer places to be; and nervous investors wouldn't be here. Today's RNS hardly makes the pulse race, but it is a sign of progress, albeit overdue. CED is larger than MEV; and of course we're also waiting upon the US to come through. All delayed due to COVID. Bottom line is, EDEN has more than enough cash for time being. And clock is ticking on seeds + Sustaine. | brucie5 | |
05/8/2020 09:47 | Sales are key. Eden seem incapable of achieving real sales - they've had 25 years and are still touting authorisations as progress. The market is not that easily fooled. | erinvale | |
05/8/2020 08:22 | Unmentionable Sales. | supersonico | |
05/8/2020 08:21 | Wow another approval, if only that is all companies had to do to be successful these days... WHAT ABOUT SALES??? | bjlk | |
05/8/2020 07:14 | New authorisation for Cedroz™ in Greece | supersonico | |
04/8/2020 07:48 | Wow all we need now is some sales. | chrischas | |
03/8/2020 18:47 | Unmentionable US patent. No 1 YEAST CELL WALL PARTICLE ENCAPSULATION OF BIODEGRADABLE PRO-PAYLOADS Unmentionable US patent. No 2 COMPOSITIONS CONTAINING A HOLLOW GLUCAN PARTICLE OR A CELL WALL PARTICLE ENCAPSULATING A TERPENE COMPONENT, METHODS OF MAKING AND USING THEM | supersonico | |
02/8/2020 00:04 | Eden is going to 0p | quazie12 | |
01/8/2020 18:59 | 15p would put Eden on a rough P/E of 1.5 assuming the Corteva deal comes through with potential values suggested. That would be a massive share price under performance and lack of recognition for that contractual arrangement. | investingisatrickygame | |
01/8/2020 10:51 | Well it's true to say runners make up time and space in the second half of a race. I will be pleased even if I come 3rd.Anything over 15p will do me just fine | northwick | |
01/8/2020 10:25 | And as the runners pass the half way stage in the 2020 Guess The share price At The End Of The Year Group 1 B Gold Cup ....... it's bjlk in the lead with 11p followed menacingly by JakNife with 2p and Cenkos third with 12p. Last year's winner Northwick, Brucie and Investing bring up the rear. Lykele. Fancy a punt? | littlealbatross2 | |
31/7/2020 16:28 | / I wonder is Antoine Boron realises how much we are relying on him to get that xxxxxx rabbit of the hat!!! | 33mick | |
31/7/2020 13:58 | Brucie5, I'm thinking we'll see more of a product launch from the distributor.. rumoured to be Lidl or Aldi a while back. Personally I would not extrapolate anything from the lofi web design but I do take you point on the Mali196. .................... Detection of bacterial pathogens including potential new species in human head lice from Mali Results show that all 600 head lice, collected from 117 individuals, belonged to clade E, specific to West Africa. Bartonella quintana, the causative agent of trench fever, was identified in three of the 600 (0.5%) head lice studied. Our study also shows, for the first time, the presence of the DNA of two pathogenic bacteria, namely Coxiella burnetii (5.1%) and Rickettsia aeschlimannii (0.6%), detected in human head lice, as well as the DNA of potential new species from the Anaplasma and Ehrlichia genera of unknown pathogenicity. .................... An ickier outbreak: Trench fever spread by lice is found in Denver. Dr. Michelle Barron, medical director of infection prevention and control at UCHealth University of Colorado Hospital, received an unusual call last month from the microbiology lab: confirmation of the third case this year of trench fever, a rare condition transmitted by body lice that plagued soldiers during World War I. Barron's epidemiological training kicked in. "Two is always an outbreak, and then when we found a third—OK, we clearly have something going on," Barron recalled thinking. Barron, who said she'd never before seen a case in her 20 years here, contacted state public health officials, who issued an advisory Thursday and said a fourth person with a suspected case had been identified. They asked physicians to be on the lookout for additional cases. | supersonico | |
31/7/2020 13:41 | Any company that is associated with the kind of website that appears to be the best that TT can muster, with the kind of product launch that is not just perennially late, but seems even now to show a complete absence of detail... almost deserves to fail. I'm not even on the bod, and I'm embarrassed. | brucie5 | |
31/7/2020 13:39 | Well that's a knockout, then: NUMBER OF PARTICIPANTS 196 subjects IN VIVO LOCATION Deguela and Lena villages, Mali RESULTS Terpenator Head Lice formulations demonstrated to be superior to competitive products | brucie5 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions